Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
FRANKFURT, May 13 (Reuters) - Bayer said on Monday its Monsanto unit, which is being investigated by French prosecutors for compiling files of influential people such as journalists in France, likely did the same across Europe, suggesting a potentially wider problem.
French prosecutors said on Friday they had opened an inquiry after newspaper Le Monde filed a complaint alleging that Monsanto - acquired by Bayer for $63 billion last year - had kept a file of 200 names, including journalists and lawmakers in hopes of influencing positions on pesticides.
On Sunday, Bayer acknowledged the existence of the files, saying it does not believe any laws were broken but that it will ask an external law firm to investigate.
"It's safe to say that other countries in Europe were affected by lists ... I assume that all EU member states could potentially be affected," Matthias Berninger, Bayer's head of public affairs and sustainability, told journalists on Monday.
While he did not say there had any illegal activity and added it was up to the external law firm to evaluate the conduct, Berninger said there were signs Monsanto had not played fairly in the use of private data.
"There have been a number of cases where - as they would say in football - not the ball was played but the man, or woman, was tackled," Berninger, who joined Bayer in January, said on a conference call.
"When you collect non-publicly available data about individuals a Rubicon is clearly crossed," regardless of whether data privacy laws were actually violated, he added.
He repeated an apology issued by Bayer over the weekend.
French public-sector research institutes Inra and CNRS on Monday said they would file criminal complaints over mishandling of personal data, after finding that some of their researchers and executives featured on the Monsanto stakeholder lists.
Bayer said in its initial statement on Sunday that "Currently, we have no indication that the preparation of the lists under discussion violated any legal provisions."
It added, "Bayer will ask an external law firm to investigate the project Monsanto commissioned and evaluate the allegations. The law firm will also inform all of the persons on the lists of the information collected about them".
Work with the PR agencies that were commissioned by Monsanto for the project at the time has been suspended, it said.
Bayer already faces potentially heavy costs from U.S. class-action lawsuits in which plaintiffs argue that Monsanto's Roundup weedkiller causes cancer.
Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalisation smaller than the price it paid for Monsanto.
Shareholders delivered a rare rebuke to CEO Werner Baumann's management team at Bayer's annual general meeting last month, with a majority voting against ratifying the executive board's business conduct in 2018. (Reporting by Ludwig Burger Additional reporting by Gus Trompiz in Paris Editing by Douglas Busvine and Frances Kerry)